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Abstract 
Colonization of urinary catheters by bacteria which 
produce urease leads to an increase in urine pH, fol-
lowed by deposition of the minerals struvite and hydrox-
yapatite. Adhesion of these encrusting deposits can be 
reduced, but not prevented, by using catheters with a 
smooth surface finish. Chemical methods for preventing 
encrustation are not completely satisfactory. A better 
way of preventing encrustation would be to prevent colo-
nization of the catheter by bacteria. This might be 
achieved by controlled release of antimicrobial agents 
directly into the urine from the catheter itself. Prelim-
inary experiments have demonstrated the feasibility of 
controlled release from solid silicone. However, a sim-
pler approach is diffusion of an antimicrobial agent from 
a solution within the retention balloon of the catheter. 
Further experiments are required to determine the con-
centrations required and whether they are achievable in 
practice. 
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Introduction 
A mechanism has been proposed for the encrustation 
of indwelling urinary catheters which involves their col-
onization by bacteria (Cox et al. , 1989a). This paper 
reviews the evidence for the proposed mechanism and 
considers its implications for the prevention of 
encrustation. 
Indwelling catheters are used to drain urine from the 
bladder of patients who are suffering from urinary 
incontinence or retention (Kunin, 1987). They consist 
of a natural rubber latex, silicone rubber or PVC tube 
which is inserted into the bladder. Most latex catheters 
are coated with silicone elastomer, Teflon or hydrogel to 
provide a smoother surface finish. The most common 
design, the Foley catheter, is inserted through the ure-
thra and is retained in the bladder by an inflatable bal-
loon (Fig. 1). The tip allows the catheter to be inserted 
(with the balloon deflated); the eye is a hole which al-
lows urine to pass into the drainage lumen. The other 
end of the catheter is connected to a drainage bag to pro-
vide a sealed system for the collection of urine. A sec-
ond lumen (the inflation lumen) connects the inside of 
the retention balloon to a side arm which terminates in 
a one-way valve. When the catheter has been inserted, 
water is injected, through this valve, to inflate the bal-
loon and so retain the catheter in position. 
Infection of the urinary tract is believed to be fol-
lowed by colonization of the catheter surface by bacteria 
(Kunin and Steele, 1985). Chemical changes then occur 
in the urine which lead to the formation of encrusting 
deposits (Bruce et al. , 1974; Hedelin et al., 1991). In 
principle, possible methods for preventing encrustation 
are to prevent: (i) the adhesion of encrusting deposits to 
the catheter surface, or (ii) chemical changes occurring 
in the urine, or (iii) colonization of the catheter by bac-
teria. Methods (ii) and (iii) involve introducing a chemi-
cal agent to the inner surface of the catheter. Controlled 
release allows the appropriate concentration to be deliv-
ered to the appropriate site, whilst relying on minimal 
nursing care or patient compliance. The catheter itself 
can provide a suitable vehicle for controlled release. 










Figure 1. Schematic diagram of a Foley catheter 
retained in the bladder by an inflated balloon. 
urease 
Figure 2. Chemical reactions which lead to an increase 
in urine pH. 
Mechanism of Encrustation 
The most common problem which accompanies uri-
nary catheterization is the formation of encrusting depos-
its on the catheter surface (Getliffe and Mulhall, 1991; 
Hedelin et al., 1985a; Kunin et al., 1987). These 
deposits form a hard mass around the eye of the catheter 
and can cause blockage of the drainage lumen. Analysis 
of the deposits identified substantial concentrations of 
ammonium, calcium, magnesium and phosphate ions 
(Bruce et al., 1974; Hedelin et al., 1984; Holt et al., 
1987). The ammonium, magnesium and some of the 
phosphate ions have been shown, by X-ray diffraction, 
to be present in the form of the mineral struvite 
(NH4MgP04.6H20) (Hukins et al., 1983). It has been 
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suggested that the calcium phosphate is present as brush-
ite (CaHP04.2H20) (Hedelin et al., 1984) but X-ray dif-
fraction, X -ray absorption spectroscopy and stoichio-
metric calculations based on the results of ion exchange . 
chromatography indicate that it is poorly crystalline 
hydroxyapatite (Holt et al., 1987; Hukins et al., 1989). 
Hydroxyapatite (HAP) has the chemical formula 
Ca5(P04)30H but is usually precipitated in an iinpure 
form in biological systems. 
Struvite occurs in urinary calculi when the urine is 
infected by bacteria (e.g., Proteus) which produce the 
enzyme urease (Griffith et al., 1976; Griffith and 
Osborne, 1987). Urease catalyses the hydrolysis of urea 
to produce carbon dioxide and ammonia. Figure 2 
shows the chemical reactions which occur, leading even-
tually to the possible production of several different 
ions. Since carbon dioxide is a weak acid (pKal = 6.4; 
pK82 = 10.3), but ammonia is a relatively strong base 
(pKb = 4.8), the urine becomes alkaline, i.e., its pH 
increases. Above a pH value of 7 .2, struvite and HAP 
are precipitated from urine (Elliot et al., 1958; Lindler 
and Little, 1986). 
It is has been proposed that this mechanism is 
responsible for catheter encrustation (Cox et al., 1989a). 
This proposal is consistent with the composition of the 
encrusting deposits and the elevated pH of urine (up to 
a value of 8) in catheterised patients (Hedelin et al., 
1991; Norberg et al., 1980). Catheter encrustation has 
been mimicked in vitro by adding urease to artificial 
urine (Hedelin et al., 1985b; Cox et al., 1988, 1989b). 
Further evidence is provided by the appearance of bac-
teria in intimate association with the encrusting deposits 
(Cox et al., 1989a; Stickler et al., 1993a). Further-
more, Proteus mirabilis has been identified as the organ-
ism most commonly isolated from encrusted catheters 
(Stickler et al., 1993b). It has also been shown that 
purified capsular polysaccharides from Proteus mirabilis 
are capable of binding magnesium ions and enhancing 
struvite formation (Domanski et al., 1994). 
Adhesion of Deposits 
Prevention 
In principle, adhesion of deposits could be prevented 
by: (i) inhibiting crystallisation of mineral deposits, or 
(ii) ensuring that there were no nucleation sites for crys-
tal growth on the catheter surface. The second method 
has the possible advantage that a surface finish with no 
nucleation sites would be so smooth that it would be 
expected to provide a poor surface for bacterial colonisa-
tion. Although both methods might be expected to 
reduce encrustation, they have yet to be explored fur-
ther, for the reasons given below. 
Encrustation of urinary catheters 
Inhibitors 
Controlled release of inhibitors or binding them to 
the catheter surface might be expected to reduce encrus-
tation. The possibility of preventing HAP deposition on 
implanted heart valves by controlled release of diphos-
phonates from silicone rings has been described in the 
literature (Levy et al., 1985). Substances, such as 
diphosphonates, inhibit calcium phosphate crystallisation 
by adsorbing on the surface of crystal surfaces and so 
prevent further crystal growth (Blumenthal, 1989). Cit-
rate is believed to inhibit HAP deposition in urine (Sutor 
et al., 1978). Recent studies indicate that oral adminis-
tration of citrates may significantly reduce crystallisation 
in urine (Wang et al., 1994). These studies were pub-
lished after the experimental feasibility studies reported 
in this paper were completed and may indicate an alter-
nate approach to preventing encrustation. 
Unfortunately, substantial encrustation can still 
occur in the presence of inhibitors. Albumin can be 
shown to inhibit HAP deposition (Gilman and Hukins, 
1994). However, albumin forms part of an in vitro 
model system in which encrustation occurs (Cox et al., 
1988, 1989b). 
Surface finish 
A smooth surface finish is expected to minimise 
encrustation but it is unlikely that a sufficiently smooth 
surface will be achieved to completely prevent its occur-
rence. Hydrogel-coated latex and all-silicone catheters 
have the smoothest surfaces (Cox, 1987, 1990) but 
encrusting deposits still adhere to them during in vitro 
experiments (Cox et al., 1988, 1989b). Diamond-like 
carbon provides a surface which is highly resistant to 
adhesion of biological materials (Higson and Vadgama, 
1993) and so might be reduce encrustation even further. 
However, it is unlikely that a catheter could be manufac-
tured and introduced into the body without any surface 
scratches which could provide nucleation sites for crys-
tallisation of encrusting deposits. 
Changes in Urine Chemistry 
Principles 
Changes which occur in the chemistry of urine, fol-
lowing colonization of the catheter surface by bacteria, 
could be prevented in two ways: (i) by reversing the 
increase in urine pH, or (ii) by preventing urease from 
hydrolysing urea. There are two plausible methods for 
achieving the second aim: to inhibit urease molecules or 
to remove them from the system. 
Changing urine pH 
Since deposition of struvite and HA is a result of 
elevated urine pH, it has been suggested that decreasing 
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the pH by acidifying the urine would prevent encrusta-
tion (Hedelin et al., 1991; Kunin, 1987). When acid 
was added to a mixture of urease and artificial urine, its 
pH dropped from a value of 8.5 to 6.5, as expected 
(Bibby and Hukins, 1993). Unfortunately, the pH then 
increased. The reason is that the pH of the system is 
controlled by the equilibrium reactions shown in Figure 
2. According to Le Chatelier8 principle, the equilib-
rium position shifts to oppose the imposed change, i.e., 
urease catalyses the conversion of more urea into ammo-
nia and carbon dioxide so that the pH rises again. In 
order to prevent the rise in pH, all the urea in the urine 
would have to be converted into ammonia which would 
then have to be neutralised by a suitable acid. This 
approach would require an unreasonably large volume of 
acid and so is not a feasible method for preventing 
encrustation (Bibby and Hukins, 1993). 
Inhibition of urease 
Urease can be inhibited by acetohydroxamic acid 
(AHA) or hydroxyurea (Hamilton-Miller and Gargan, 
1979; Carmignani et al., 1980). Only AHA has been 
used as a pharmaceutical agent (to prevent formation of 
urinary tract calculi as a result of infection); its recom-
mended dosage is 250 mg, three to four times daily. 
However, in vitro experiments suggest that a concen-
tration of AHA of greater than 3.8 mg cm-3 is required 
to prevent a rise in urine pH (Griffith et al., 1973). 
Although AHA has been successfully used to reduce 
catheter encrustation, patients suffered from side effects 
which can include loss of appetite, mental depression, 
nausea and vomiting (Burns and Gauthier, 1984). It 
may be that the risk of side effects would not be so great 
if AHA were delivered directly to the site of bacterial 
colonization. However, the seriousness of these side 
effects suggests that AHA is unlikely to be acceptable 
for routine prevention of encrustation. 
Removal of urease 
In principle, the problem could be solved by digest-
ing urease molecules with an proteolytic enzyme. Early 
research on the action of proteolytic enzymes produced 
ambiguous results (Sumner, 1951), perhaps because 
pure, well characterised enzymes and substrates were 
not then available. We have updated this research using 
a selection of enzymes which are active at neutral or 
alkaline pH values: trypsin, chymotrypsin, papain, ficin, 
proteinase k and subtilisin Carlsberg. 
All enzymes were obtained from Sigma Chemical 
Company (St. Louis, Missouri, US). Ficin was a crude 
preparation; all other proteolytic enzymes were crystal-
lized and lyophilized by the supplier. Jack bean urease 
was dissolved in 0.02 M sodium phosphate buffer (pH 
7) which was adjusted to the optimum pH of the proteo-
lytic enzyme being investigated by addition of sodium 
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hydroxide. The concentration of the urease was 15 
mg.cm-3, corresponding to an activity of approximately 
855 IU.cm-3• Urease solution was incubated at 37°C 
before adding protease and all digestions were per-
formed at this temperature. The proteolytic enzyme was 
added so its mass was 1130 times that of the urease. 
This ratio of proteolytic enzyme/urease was chosen arbi-
trarily, although it ensured that the substrate (urease) 
was present in excess. Although the same mass was 
used for each of the six proteolytic enzymes, they may 
have had different activities. However, the aim of this 
experiment was to compare the effects of each enzyme 
in its commercially available form. The activity of the 
urease solution was determined before the addition of 
proteolytic enzyme from the mean of four assays (Bibby 
and Hukins, 1992). Two samples were removed from 
the solution at time periods of 5, 15 and 25 minutes; the 
urease activity at each time was determined as the mean 
assay from the two samples. A control sample of the 
original urease solution was incubated at 3rC with no 
enzyme and the activity determined after a period of 30 
minutes (mean of two assays). Digestion experiments 
were repeated four times for enzymes which were found 
to reduce urease activity to less than 80% of its initial 
value. 
Three proteolytic enzymes (subtilisin Carlsberg, 
chymotrypsin and proteinase k) reduced urease activity 
to less than the 80% level in the time period of the 
experiment. Proteinase k was the only enzyme which 
reduced the activity to less than 60%; its results are 
shown in Figure 3a. For both subtilisin Carlsberg and 
chymotrypsin, the reduction was to not less than the 
70% level. These results are consistent with proteinase 
k being especially active towards native enzymes and 
suggests that it could prove useful in removing urease. 
Application of immobilised proteinase k 
There are two reasons for using proteinase k in an 
immobilised form: (i) to prevent it being flushed from 
the catheter, and (ii) to prevent it digesting itself. Loss 
of proteolytic enzyme would lead to depletion of supply; 
compensating for this loss with excess enzyme could 
prove an expensive solution to the problem. Enzymes 
are commonly immobilised on to hydrogels, so there 
should be no problem in immobilising proteinase k on to 
the surface of the drainage lumen of a hydrogel-coated 
catheter. Therefore, the experiments described in the 
previous section were repeated with immobilised 
proteinase k. 
Proteinase k immobilised on agarose was purchased 
from Sigma Chemical Company. Its activity was com-
parable to that of the free enzyme. However, in this 
experiment, the ratio of proteolytic enzyme to urease 
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Figure 3. Effect of proteinase k on the activity of 
urease in solution. In (a) the proteinase k was also in 
solution, in (b) it was immobilised. Further details are 
given in the text. 
minutes at 37°C and the immobilised enzyme was then 
removed by centrifugation for 5 minutes. A control 
contained no proteolytic enzyme and was incubated for 
25 minutes. Four experiments were performed. 
Figure 3b shows that the immobilised enzyme 
caused an even greater and more rapid digestion of 
urease than the free enzyme. However, a problem still 
remains in preventing catheter encrustation by immobil-
ising proteinase k on the surface of the drainage lumen. 
Urease is present in the urine of patients infected with 
the bacteria which produce it, as a result of cell lysis 
(Griffith and Osborne, 1987). It has been suggested that 
this extracellular urease is important in the formation of 
kidney stones (Griffith and Osborne, 1987). However, 
the pH of the urine surrounding bacteria which produce 
urease can rise without cell lysis, i.e., intracellular 
urease may also be important (Griffith et al., 1973). 
Encrusta ) 10 of urinary catheters 
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figure 4. Incorporation of a controlled release matrix 
a> (a) a lining and (b) a plug near the eye of the 
Cltheter. 
Thus, extensive studies of the relative importance of 
i!ltracellular and extracellular urease would be needed 
~fore this approach was proved to be of value. 
Prevention of Bacterial Colonization 
Eackground 
Since improving the surface flnish of a catheter is 
uolikely to prevent encrustation and the chemical meth-
ods described above all present problems, it appears rea-
scmable to solve the problem at its source, i.e., to pre-
vent the colonization of the catheter by bacteria. Pre-
vention of infection would prevent encrustation. Infec-
tion of the urine in a catheter is already perceived as a 
problem, albeit separate from that of encrustation, in the 
c3theterized patient (Kunin and Steele, 1985; Slade and 
Gillespie, 1985). It is believed to occur by two different 
routes: (i) through the drainage system (intraluminally), 
a11d (ii) between the outer surface of the catheter and the 
ufethral mucosa (periurethrally) (Brehmer and Marsden, 
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1972; Kunin, 1987). Rigorous cleansing routines reduce 
periurethral infection (Brehmer and Marsden, 1972) and 
closed drainage systems minimise intraluminal infection 
(Gillespie et al., 1967; Kunin, 1987); however, once 
infection is introduced into the system, closed drainage 
serves no purpose. Application of bladder washout solu-
tions also breaks closed drainage systems (Kirk et al., 
1979; Warren et al., 1978). If intraluminal infection is 
prevented, infection still proceeds by the periurethral 
route (Gillespie et al., 1983). 
The antimicrobial properties of silver (Foye, 1977) 
have been exploited in two ways. A randomized clinical 
trial of catheters coated with silver showed a statistically 
significant decrease in the incidence of bacteriuria after 
6 days (Liedberg and Lundeberg, 1990). Such a cathe-
ter may have a short-term effect in minimising encrusta-
tion, but the long-term effects are unknown. A plug 
which contains silver has been introduced for attaching 
the catheter to the drainage bag (Silverline, Clinimed, 
High Wycombe, U.K.). This antimicrobial layer may 
prevent migration of bacteria from the drainage bag into 
the catheter but does not address the problem of peri-
urethral infection. 
An alternative approach to preventing infection and, 
hence, encrustation, is the prophylactic application of 
antimicrobial agents. Controlled release of these agents 
has several advantages: (i) application of the agents to 
the site of infection, (ii) avoidance of breaking a closed 
drainage system, (iii) reduction in nursing care, and (iv) 
use of the catheter as a means of introducing the agent. 
A possible problem with this approach is that the routine 
use of antimicrobial agents may give rise to resistant 
strains (Britt et al., 1977; Butler and Kunin, 1968a; 
Dudley and Barriere, 1981). However, this is likely to 
be more of a problem with bladder washout solutions 
where the agent must be applied intermittently. It has 
been found that catheters impregnated with antimicrobial 
agents lose their activity within 48 hours (Butler and 
Kunin, 1968b). More recent work on release from lin-
ings of the walls of catheters provides little detail 
(Huajin, 1988; Mochizuki et al., 1985). An alternative 
approach involves ionically bonding antimicrobial agents 
to the catheter wall; molecules are released as the bonds 
break (Sakamoto et al., 1985). 
Here the construction of the catheter is exploited as 
a means of releasing antimicrobial agents into the urine. 
One approach involves impregnating silicone with the 
agent. This is achieved by mixing liquid silicone with 
the agent; the mixture subsequently cures so that the 
agent is incorporated into solid silicone. The silicone 
could be introduced as a plug within the tip of the cathe-
ter (Fig. 4a) or as a lining in the drainage lumen (Fig. 
4b). The other approach exploits the catheter balloon as 
a reservoir for a solution of antimicrobial agent which 
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could then diffuse through the wall of the balloon into 
the residual urine in the bladder and then pass through 
the drainage lumen. 
Preliminary experiments were performed with chlor-
hexidine (in solid silicone plugs) and mandelic acid (in 
solution, filling the retention balloon of all-silicone cath-
eters). Mandelic acid has the advantage that it is effec-
tive against Proteus in the biofilms which coat the drain-
age lumen of encrusting catheters (Stickler and Hewett, 
1991; Stickler et al., 1991). These biofilms consist of 
a mixture of bacteria, macromolecules and minerals; the 
bacteria are protected from antibiotics by the barrier 
provided by their environment (Cox et al., 1989a; Nick-
el et al., 1985; Ramsay et al., 1989). A further advan-
tage of mandelic acid is that it does not give rise to 
resistant strains (Robertson and Norton, 1990). How-
ever, Proteus mirabilis, which was the commonest spe-
cies colonizing a sample of encrusted catheters (Stickler 
et al., 1993a,b), is especially sensitive to trimethoprim, 
cefuroxime, nalidixic acid and norfloxacin (Garrod et 
al., 1981); it would, therefore, be worth investigating 
controlled release of these antibiotics from catheters in 
future experiments. 
Chlorhexidine release from silicone 
Chlorhexidine has been claimed to reduce infection 
on latex catheters (Zinsser et al., 1968). However, 
some species of Proteus are not very susceptible. The 
controlled release of chlorhexidine diacetate from ethyl 
cellulose, hydrogels, latex and biodegradable protein 
have been investigated (Friedman and Golomb, 1982; 
Mirth et al., 1989; Mochizuki et al., 1985; Steinberg et 
al., 1990). Most of the devices have been developed for 
dental applications. Factors which affect the rate of re-
lease of chlorhexidine include: (i) the mass of chlorhexi-
dine incorporated, (ii) the surface area, and (iii) the per-
meability of the matrix (Friedman and Golomb, 1982; 
Mirth et al., 1989; Mochizuki et al., 1985; Steinberg et 
al., 1990). Permeability of silicone matrices for the re-
lease of diphosphonates has been increased by adding 
polyethylene glycol (PEG); the PEG is then dissolved 
out in acetone, leaving pores in the matrix (Golomb et 
al., 1987). However, we found that chlorhexidine pre-
vents silicone from curing in the presence of PEG. In 
our experiments, attempts were made to increase the po-
rosity of the matrix by adding sodium chloride. The so-
dium chloride was expected to dissolve in water, intro-
ducing pores into the matrix. Experiments were per-
formed with three formulations of silicone: (i) Dow 
Corning silicone elastomer (MDX4-4210; Dow Corning 
Corp., Medical Products, Midland, Michigan, USA), 
(ii) Provil L dental silicone (Bayer Dental, Leverkusen, 
Germany), and (iii) Dow Corning silicone gel (Q7 
2218). All three silicones are prepared by mixing tWo 
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Table 1. Compositions of the samples used for control-
led release experiments. 
Silicone1 Chlorhexidine2 NaC13 
MDX4 33% 0% 
MDX4 40% 0% 
MDX4 30% 15% 
Provil L 20% 0% 
Provil L 30% 0% 
Provil L 20% 15% 
Q7 30% 0% 
Q7 40% 0% 
Q7 30% 15% 
1Dow Corning silicone elastomer (MDX4-4210), Provil 
L dental silicbne or Dow Corning silicone gel (Q7 
2218). 
2Expressed as the percentage of the total mass of the 
specimen consisting of chlorhexidine diacetate. 
3Expressed as the percentage of the total mass of the 
specimen consisting of NaCl. 
components; in each case, incorporation of chlorhexidine 
diacetate produced a stronger, more rigid solid. The 
experiments tested release from one side of discs of 
material, to simulate release from the surface lining of 
a catheter. 
Table 1 lists the compositions of the specimens 
used. The particle size of the chlorhexidine diacetate 
was determined by image analysis; 97% of the area 
occupied by 1250 particles consisted of particles whose 
area was less than 24 p.m2• For the sodium chloride 
added to some specimens, the corresponding particle 
area was less than 80 p.m2• All samples were thorough-
ly mixed and cast as sheets; air bubbles were removed 
by placing the mixtures in a vacuum for 15 minutes. 
Since Dow Corning Q7 takes at least 24 hours to cure at 
room temperature, these samples were rotated at 0.7 
rad.s-1 to prevent settling of chlorhexidine diacetate. 
Samples were tested as discs of area 1. 77 cm2 which 
were backed with an impermeable coating to ensure that 
release was restricted to a single face. 
Each disc was placed in a fixed volume of distilled 
water in a conical flask that had been treated with Sig-
macote (Sigma, St. Louis, MO), because chlorhexidine 
is believed to be affected by glass (E. Chan tier, personal 
communication). For each of the formulations listed in 
Table 1, six discs were tested . Other flasks contained 
solutions of chlorhexidine to monitor its stability during 
the course of each experiment. Samples were removed 
periodically and the concentration of chlorhexidine 
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Figure S. Cumulative mass of chlorhexidine diacetate 
released from silicone gel Q7 for specimens containing 
30% (circles) and 40% (squares) loadings (Table 1). 
Error bars represent one standard deviation. 
diacetate monitored by ultraviolet absorbance at a wave-
length of 276 nm. 
Chlorhexidine diacetate was released from all the 
formulations listed in Table 1 but Dow Corning Q7 was 
shown to be the most suitable matrix for this application. 
The release from MDX4 was comparatively slow (cumu-
lative mass released was about 2 mg in 300 hours for a 
40% loading) when compared with Q7 (over 5 mg in 
300 hours for 40% loading) and Provil L (about 5 mg in 
300 hours for 30% loading). · However, Provil L 
showed an initial rapid release, while that from Q7 was 
highly linear (r = 0.99), as shown in Figure 5. Fur-
thermore, it was found possible to achieve a higher 
loading of chlorhexidine diacetate in Q7 ( 40%) than in 
Provil L (30% ). All experiments on samples containing 
sodium chloride were discontinued because of their rapid 
physical deterioration. 
The concentration of chlorhexidine released into the 
urine of a catheterised patient can be estimated. From 
the slope of Figure 5 (0.0204 ± 0.0008 mg.h-1), the 
concentration of chlorhexidine in the urine of an elderly 
patient passinJ typically 800 cm3 per day would be 
0.006 mg.cm- . Although this is less than in bladder 
washout solutions (0.2 mg.cm-3), it is possible that 
lower concentrations would be effective in continuous 
application. 
Mandelic acid release from the balloon 
The experiments described in this section show that 
mandelic acid can diffuse through the retention balloon 
of an all-silicone catheter. Thus, the catheter itself can 
be used as the vehicle for controlled release. The ad-
vantages of using mandelic acid for controlling catheter 
infection have been described above. 
An all-silicone Foley catheter (size 16 or 18; Bard 
Ltd., Clacton-on-Sea, U.K.) was introduced through a 
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Figure 6. Apparatus used to investigate release of 
mandelic acid from an inflated retention balloon. 
screw adapter into one of the side necks of a triple-
necked flask (250 cm3 capacity), as shown in Figure 6. 
Distilled water (125 cm3) was added to the flask and cir-
culated through the drainage lumen of the catheter by 
means of a peristaltic pump. (A limited number of 
experiments using artificial urine yielded closely similar 
results.) The balloon was inflated with mandelic acid 
solution (30 cm3). Concentrations of 0.025, 0.050, 
0.075, 0.100 and 0.125 g.cm-3 were used. Six catheters 
were used for each concentration studied. Samples 
(0.08-0.5 cm3) of the circulating water were removed 
periodieally through the central neck of the flask. The 
mandelic acid concentration was monitored by ultraviolet 
absorption at a wavelength of 256 nm. Sink conditions 
were maintained throughout by changing the circulating 
liquid every time the mandelic acid concentration 
exceeded 0.016 g.cm-3• (This ensured that the release 
of the mandelic acid from the balloon was not inhibited 
by its concentration in the surrounding liquid. Thus, the 
experiments mimicked release into the drainage lumen of 
a catheter where the substance released would be flushed 
into the collecting bag.) Six different catheters were 
used for each mandelic acid concentration investigated. 
Figure 7 shows that mandelic acid diffuses through 
the catheter balloon; Figure 7a compares the results for 
all five concentrations used. The results for the most 
concentrated mandelic acid solutions are incomplete 
because the balloons persistently ruptured. However, a 
separate series of experiments showed no decrease in 
balloon strength, as measured by bursting pressure, after 
exposure to mandelic acid solution. In Figure 7b, the 
results for all concentrations are shown to lie on a single 
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smooth curve when the cumulative mass of mandelic 
acid released is expressed as a percentage, P, of the 
initial mass in the balloon. This curve can be repre-
sented by the second-order polynomial of the form: 
P = at- btl (1) 
when t is the time in hours, a = 0.207 ± 0.005 h-1 and 
b = (1.32 ± 0.08) x 104 h-2. In a short time interval, 
l:lr, after a time interval, r, has elapsed, the mass, m, of 
mandelic acid released is then given approximately by: 
m = (fDo/100)(a - 2hT)I:lr (2) 
where 111o is the initial mass of mandelic acid in the bal-
loon. 
It is clear, from the results of Figure 7, that man-
delic acid was still being released after a period of over 
4 weeks. Eq. 2 shows that between days 10 and 11, the 
mass of mandelic acid diffusing through the balloon was 
0.104 g for a filling solution with a concentration of 0.1 
g.cm-3. For an elderly person expressing an average of 
800 cm3 of urine per day, this corresponds to a mandelic 
acid concentration of 0.13 mg.cm-3. Mandelic acid is 
bactericidal in urine at a concentration of 5 mg.cm-3 
(Rosenheim, 1935). Further research needs to be per-
formed to determine: (i) the minimum concentration at 
which it would be effective for preventing encrustation, 
(ii) methods for increasing the diffusion rate, and (iii) 
methods for increasing the concentration of mandelic 
acid in the balloon. Also, there are many other potenti-
ally useful antimicrobial agents whose diffusion proper-
ties have yet to be investigated. Release through a 
membrane can also be achieved when drugs are encapsu-
lated into micelles or reversed micelles (Juni et al., 
1978). 
Conclusions 
There do not appear to be any satisfactory chemical 
methods for preventing catheter encrustation. Although 
acidic bladder washout solutions may be helpful for 
removing encrusting deposits, once they have formed 
(Getliffe, 1994), acidification of the urine cannot prevent 
encrustation (Bibby and Hukins, 1993). The reason is 
that the effect of adding acid is rapidly reversed by the 
enzyme urease, produced by the bacteria which colonize 
the catheter surface. It is the reactions which are cata-
lysed by urease (Fig. 2) which are responsible for en-
crustation in the first place. Urease inhibitors which are 
presently available have side effects that make them un-
suitable for routine administration (Burns and Gauthier, 
1984). However, if a safe and effective urease inhibitor 
could be developed, it might have considerable potential 
for preventing encrustation. Proteolytic enzymes, espe-
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Figure 7. (a) Cumulative mass of mandelic acid 
released from a silicone retention balloon filled with 
solutions of concentration: 0.125 (diamonds), 0.100 
(large squares) , 0.075 (triangles), 0.050 (crosses) and 
0.025 (small squares) g.cm-3. (b) When the results for 
all concentrations are expressed as a percentage of the 
mass of mandelic acid available for release, they lie on 
the same smooth curve. 
extracellular urease in infected urine, as a result of 
bacterial cell lysis, intracellular urease may also be 
important (Griffith et al., 1973). Enzymes could be 
immobilised on the catheter surface to digest the 
extracellular urease, but it is difficult to devise a method 
to digest intracellular urease. One possibility is to also 
immobilise an enzyme which digests bacterial cell walls 
to the catheter surface. However, this possibility has 
not been seriously investigated. 
Smooth catheter surfaces are less likely to be 
encrusted than rough surfaces. However, some encrus-
tation occurs on the smoothest surfaces currently avail-
able (Cox et al., 1988, 1989b). Thus, smooth surfaces, 
e.g., those of all-silicone or hydrogel-coated latex cathe-
ters, are beneficial but cannot prevent encrustation 
completely. 
Encrustation of urinary catheters 
The most promising approach to preventing encrus-
tation is to prevent the catheter from being colonized by 
the bacteria which are ultimately responsible for the 
problem. Controlled release of antimicrobial agents 
would ensure that they targeted the site of infection and 
is expected to be more effective than intermittent appli-
cation. In any case, application of antibiotic bladder 
washout solutions breaks the closed drainage system, 
and so, could lead to renewed infection (Kirk et al., 
1979; Warren et al., 1978). Preliminary experiments 
show that controlled release is feasible. However, it has 
yet to be determined whether it can deliver concentra-
tions of antimicrobial agents which are sufficiently high 
to prevent encrustation. 
Using the retention balloon of the catheter as the 
reservoir for controlled release has the advantage that no 
change in the design of the conventional Foley catheter 
is required. In a patient, the release of antimicrobial 
agent in the urine could be monitored by periodically 
determining the concentration remaining in the solution 
filling the balloon. If it had fallen to an unacceptably 
low level, it could be replenished without disturbing the 
catheter. However, further experiments need to be per-
formed to develop suitable solutions. 
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Discussion with Reviewers 
K.A. Getliffe: Urinary catheters have been manufac-
tured with a range of coatings designed to combat cathe-
ter-associated infection and/or encrustation. Where suc-
cess has been demonstrated, it tends to be in the short-
term only. It seems likely that this may be due to depo-
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sition of proteins from body fluids on the catheter sur-
face where they then mask the specially applied coating. 
What are your views on this? 
R.J.C. McLean: Throughout this paper, considerable 
attention is given to the properties of catheter surfaces 
and their influence on bacterial and crystal adhesion. 
One must consider that in a dirty system such as the uri-
nary tract, any surface will encounter urine components 
and may, thus, acquire a conditioning film of macro-
molecules (Reid et al., 1992). Such a film will mask 
the underlying surface and interfere with any crystal-
preventing properties that it has. 
Authors: This problem is likely to occur when films of 
proteins, polysaccharides or other organic deposits are 
formed on the catheter. Ideally, one would wish to de-
velop a surface coating with a sufficiently low surface 
energy to inhibit the adhesion of these deposits. Thus, 
we are concerned to minimize the adhesion of all foreign 
substances, including macromolecules as well as inor-
ganic crystals and bacteria. Note also that a smooth 
surface coating on the catheter will cover inhomo-
geneities in the bulk material which might otherwise act 
as nucleation sites for crystallization of struvite or 
hydroxyapatite. 
K.A. Getliffe: There is some evidence, from animal 
studies, that acidic solutions disrupt the mucus layer 
lining the bladder mucosa. Would continuous slow re-
lease of mandelic acid from the catheter balloon present 
an unacceptable risk of damage to the bladder tissue? 
Authors: The answer to this question depends on how 
the pH of the urine affects disruption of the mucus layer 
and would have to be answered experimentally. How-
ever, there are two important points to note. One is that 
infected urine may have an abnormally high pH value so 
that acidification would not then be expected to have an 
adverse effect. The problem of damage by acidification 
could then be overcome by filling the balloon with an 
acid solution only when the urine showed signs of ele-
vated pH. The other point is that intermittent acidifica-
tion with bladder wash-out solutions is likely to lead to 
much lower pH values, if it is to be effective in remov-
ing encrusting deposits, than those arising from gradual 
controlled release of mandelic acid. 
D.J. Stickler: There are reports in the literature of the 
poor activity of chlorhexidine against Proteus mirabilis 
in urine (e.g. , Stickler et al., 1987). Dance et al. 
(1987) also reported a large outbreak of urinary tract 
infections by a chlorhexidine resistant strain of Proteus 
mirabilis in catheterized patients in a hospital where the 
catheter care policy involved the extensive use of chlor-
hexidine. It seems to me that the release of this anti-
septic from catheters, as suggested by the authors, could 
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be counter productive and select for precisely the species 
that produces the problem of encrustation. Would the 
authors please comment on this possibility? 
Authors: Chlorbexidine was chosen to test the feasibil-
ity of controlled release of an antimicrobial agent from 
a catheter. The reason for this choice was that it bas 
been claimed to reduce infection on catheters, is a com-
ponent of some bladder wash-out solutions and can be 
released from a range of solid matrices, as described in 
the text. However, we did not wish to imply that it was 
the most suitable antimicrobial agent for preventing 
infection by Proteus mirabilis. Resistance and related 
problems are important considerations, as we outlined in 
the main text. The references cited by the reviewer 
imply that an alternative agent should be used in further 
studies of controlled release. 
D.J. Stickler: How does mandelic acid pass from the 
catheter balloon into the urine? Could the authors com-
ment on the nature of the chemical agents that are likely 
to be able to diffuse in this way? 
Authors: We believe that the mechanism is diffusion 
through the material of the balloon. Therefore, we 
would expect that the diffusion rate would be greater for 
low molecular weight compounds with hydrophobic 
groups which would improve their miscibility with the 
balloon material. Oil soluble dyes, such as Sudan IV, 
can diffuse through a silicone membrane whilst methyl-
ene blue, a water soluble dye, cannot (Chien, 1980). 
Preliminary studies on diffusion through catheter bal-
loons showed that molecular weight (in the range 36-
898) did not limit the ability of a substance to diffuse, 
although it may have influenced the rate of diffusion 
(Bibby, 1992). The most important factor was whether 
the substance had some hydrophobic nature. For exam-
ple, oil red 0, a large hydrophobic molecule (molecular 
weight, 408), was found to diffuse through the mem-
brane, while hydrochloric acid did not. 
D.J. Stickler: What concentrations of mandelic acid 
were achieved in the bladder when artificial urine was 
used as an alternative to distilled water? Have you used 
human urine in these experiments? 
Authors: Substituting artificial urine for distilled water 
made no appreciable difference to the results presented 
in Figure 7a. It is important to note that these results 
cannot be directly related to mandelic acid concentration 
in the bladder because experiments were performed un-
der sink conditions, i.e., the liquid was changed when-
ever the mandelic acid concentration exceeded a value of 
0.016 g.cm-3. The reasons for this experimental design 
are given in the text. We have not used human urine 
because its composition is not constant, and, therefore, 
its use introduces a hidden variable into the design of the 
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experiment. 
R.J.C. McLean: It bas been our experience that cathe-
ter surfaces become colonized quite rapidly by biofilm-
forming bacteria. Any adhesion of a microorganism or 
its surface region, e.g., capsule, will alter and influence 
catheter chemistry. When growing as biofilms, bacteria 
can create microenvironments in their immediate vicinity 
which can be chemically quite different from the bulk 
urine environment (McLean et al., 1991). In addition, 
surface polymers of bacteria can also influence struvite 
crystal growth (Clapham et al., 1990; Dumanski et al., 
1994). While catheter chemistry is important in control-
ling mineralization, it needs to be addressed in context 
with other chemical and biological features. 
Authors: This supports our conclusion that the most 
promising approach to preventing encrustation is to pre-
vent the catheter from being colonized by the bacteria 
which are ultimately responsible for the problem. 
R.J.C. McLean: Do the authors have any information 
on the physical structure of the catheter surface as it 
directly pertains to nucleation of struvite and/or hydrox-
yapatite (i.e., do different catheter materials promote or 
inhibit mineral growth)? 
Authors: We are not aware of any materials suitable 
for coating the surface of catheters which inhibit growth 
of mineral crystals. However, a smooth surface is less 
likely to provide nucleation sites for crystallization than 
a rougher surface. Scanning electron micrographs of 
silicone catheters encrusted in vitro show struvite crys-
tallizing at the intersection of surface ripples with 
hydroxyapatite deposits between the crystals of struvite 
(Cox, 1988). However, during an in vitro test lasting 
for 11 weeks, there was no significant difference be-
tween the mass of mineral deposited on hydrogel-coated 
latex, latex coated with silicone elastomer and all-sili-
cone catheters (Cox et al., 1989b). 
R.J.C. McLean: The data pertaining to the kinetics of 
antibiotic release from catheters is interesting. Have the 
authors tested any of these? 
Authors: We have not tested any of these ideas on sys-
tems containing bacteria. Optimizing the system being 
used could well prove to be an important part of any 
such testing programme. 
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